Avient Corp
Avient Corp operates in the Chemicals industry within the Materials sector, generating revenue through the production and sale of specialty chemical products.
Business. Avient Corp (NYSE: AVNT) is a materials company operating within the chemicals industry. The firm generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments and geographic mix are not provided. The company is primarily listed on the New York Stock Exchange under the ticker AVNT.K.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
- Congressional trades
- CongressLisa McClain — Avient Corporation Common Stock2025-06-11 · Republican · MI · Purchase · $1,001 - $15,000
- CongressJosh Gottheimer — Avient Corporation2022-06-21 · Democrat · NJ · Sale · $1,001 - $15,000
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Avient Corp (NYSE: AVNT) is a materials company operating within the chemicals industry. The firm generates revenue through a model combining volume and price for commodity grades with specialty premiums for branded formulations. Specific details regarding operating segments and geographic mix are not provided. The company is primarily listed on the New York Stock Exchange under the ticker AVNT.K.
Avient Corp maintains a capital structure characterized by significant leverage, with long-term debt of $1.92 billion against total equity of $2.37 billion, resulting in a debt-to-equity ratio of 0.81. The company holds a market capitalization of $3.43 billion and trades at a price-to-earnings ratio of 41.88, while the enterprise value-to-EBITDA multiple stands at 26.30. Liquidity is assessed as medium risk, with a key flag noting that net cash is negative after subtracting total debt. Operating cash flow of $301.6 million supports capital expenditures of $106.6 million, indicating positive free cash flow generation despite the leveraged balance sheet.
Profitability metrics indicate modest returns on capital, with a return on equity of 3.45% and a return on assets of 1.36%. The company reported revenue of $3.26 billion, generating a gross profit of $1.02 billion and operating income of $203.5 million. Net income stands at $81.9 million. These returns are derived from a gross margin of approximately 31.2%, reflecting the typical margin profile for specialty chemicals manufacturers, though the low ROE suggests limited leverage of equity to generate earnings relative to the asset base.
The company’s operational footprint is global, as evidenced by its subsidiary structure which includes entities in the Netherlands, Saudi Arabia, Singapore, South Africa, Sweden, Switzerland, Taiwan, and Thailand. This geographic dispersion suggests a diversified revenue base across multiple international markets, reducing reliance on any single regional economy. The presence of subsidiaries in both developed and emerging markets indicates a strategy to capture growth opportunities across varied economic cycles.
Growth trajectory analysis is limited by the absence of historical period data in the current input. However, the current revenue base of $3.26 billion provides a scale reference for future performance evaluation. The company’s ability to maintain or grow this revenue stream will depend on its capacity to expand its specialty chemical offerings and penetrate new markets through its global subsidiary network.
Risk factors include medium liquidity risk and low dilution risk. The negative net cash position highlights the importance of maintaining strong operating cash flows to service debt obligations. The low dilution risk suggests that the company is not currently engaging in significant equity issuance, preserving value for existing shareholders. The key flag regarding negative net cash serves as a critical monitor for financial flexibility.
Recent observations include the identification of multiple international subsidiaries through EDGAR filings, confirming the company’s global operational structure. No specific news events or transcript observations were provided that indicate recent strategic shifts or material corporate actions. The reconciler events noted are system-level processing logs and do not represent material business developments.
- Avient Corp operates with a high debt-to-equity ratio of 0.81, indicating significant financial leverage.
- The company generates positive operating cash flow of $301.6 million, which exceeds its capital expenditures of $106.6 million.
- Profitability is modest, with a return on equity of 3.45% and a return on assets of 1.36%.
- The global subsidiary structure suggests a diversified geographic revenue base across multiple international markets.
- Liquidity risk is assessed as medium, with a key flag noting negative net cash after debt subtraction.
- Dilution risk is low, indicating no immediate pressure from equity issuance.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- SVP, Chief Financial Officer · Restricted Stock Units → Common StockAcquired 6 357grant · 2026-06-01
- SVP, President SEM · Restricted Stock Units → Common StockAcquired 6 360grant · 2026-02-20
- Director, Chairman, President & CEO · Restricted Stock Units → Common StockAcquired 63 480grant · 2026-02-20
- SVP, President CAI · Restricted Stock Units → Common StockAcquired 9 300grant · 2026-02-20
- SVP, Global Supply Chain · Restricted Stock Units → Common StockAcquired 3 060grant · 2026-02-20
- SVP, Gnrl Counsel & Secretary · Restricted Stock Units → Common StockAcquired 7 290grant · 2026-02-20
- SVP & Chief Financial Officer · Restricted Stock Units → Common StockAcquired 12 630grant · 2026-02-20
- SVP, New Bus Dev & Mktg Exc · Restricted Stock Units → Common StockAcquired 3 210grant · 2026-02-20
- SVP & CHRO · Restricted Stock Units → Common StockAcquired 6 450grant · 2026-02-20
- SVP, Chief Technology Officer · Restricted Stock Units → Common StockAcquired 3 960grant · 2026-02-20
- SVP, Gnrl Counsel & Secretary · Restricted Stock Units → Common StockDisposed 1 836exercise · 2026-02-19
- SVP, President CAI · Restricted Stock Units → Common StockDisposed 2 280exercise · 2026-02-19
- Director, Chairman, President & CEO · Restricted Stock Units → Common StockDisposed 18 403exercise · 2026-02-19
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Capex To Revenuecapital_expenditure / revenue
- AVIENT CORPORATION Market data — financials · 2026-07-27
- reconciler_enqueue (reconciler) on AVNT.K · 2026-07-27
- Avient Corp HA canonical relationships · 2026-07-27
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,04 %$155M
- Investment Managers · as of 2026-03-310,04 %$181M
- Investment Managers · as of 2026-03-310,04 %$51M
- Investment Managers · as of 2026-03-310,03 %$83M
- Investment Managers · as of 2026-03-310,02 %$36M
- Institutional Investor · as of 2026-03-310,02 %$65M
- Investment Managers · as of 2026-03-310,02 %$107M
- Investment Managers · as of 2024-12-310,02 %$54M
- Investment Managers · as of 2026-03-310,02 %$33M
- Institutional Investor · as of 2026-03-310,01 %$57M
- Investment Managers · as of 2024-06-300,01 %$485M
- Funds · as of 2026-03-310,01 %$67M
- Investment Managers · as of 2026-03-310,01 %$49M
- Institutional Investor · as of 2026-03-310,01 %$37M
- Institutional Investor · as of 2022-09-300,01 %$0M
- Investment Managers · as of 2026-03-310,01 %$42M
- Investment Managers · as of 2026-03-310,01 %$86M
- Investment Managers · as of 2026-03-310,01 %$15M
- Investment Managers · as of 2025-12-310,00 %$319M
- Investment Managers · as of 2026-03-310,00 %$130M
- Investment Managers · as of 2026-03-310,00 %$7M
- Institutional Investor · as of 2026-03-310,00 %$61M
- Investment Managers · as of 2026-03-310,00 %$23M
- Brokerage Firms · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$4M
- Brokerage Firms · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$25M
- Investment Managers · as of 2026-03-310,00 %$6M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
Leadership
- Ashish K. KhandpurPresident, Chief Executive Officer
Insider activity
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 049 · 2026-06-30
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- Director · Common StockOther 1 072 · 2026-03-31
- SVP, President CAI · Common StockOther 2 280 · 2026-02-19
- SVP, President CAI · Common StockOther 1 260 @ $42,51$54K · 2026-02-19
- SVP, Gnrl Counsel & Secretary · Common StockOther 889 @ $42,51$38K · 2026-02-19
- SVP, Gnrl Counsel & Secretary · Common StockOther 1 836 · 2026-02-19
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating cash flow (annual): USD 301.6MUnknown
- Current assets (annual): USD 1.4BUnknown
- Capex (annual): USD 106.6MUnknown
- Operating income (annual): USD 203.5MUnknown
- Total assets (annual): USD 6.03BUnknown
- Cost of revenue (annual): USD 2.24BUnknown
- Current liabilities (annual): USD 846.3MUnknown
- Long-term debt (annual): USD 1.92BUnknown
- Revenue (annual): USD 3.26BUnknown
- Shareholders' equity (annual): USD 2.37BUnknown
- EPS (basic) (annual): USD-PER-SHARES 1Unknown
- Gross profit (annual): USD 1.02BUnknown
- Net income (annual): USD 81.9MUnknown
- Pre-tax income (annual): USD 111.7MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 1Unknown
- R&D expense (annual): USD 96.7MUnknown
- Net income (annual): USD 169.5MUnknown
- Operating income (annual): USD 329.3MUnknown
- Shareholders' equity (annual): USD 2.31BUnknown
- R&D expense (annual): USD 98.7MUnknown
- EPS (diluted) (annual): USD-PER-SHARES 2Unknown
- Pre-tax income (annual): USD 224.8MUnknown
- Revenue (annual): USD 3.24BUnknown
- Gross profit (annual): USD 1.06BUnknown